Ultima Labs
3rd Party Tested & Certified Research Grade Peptides
CJC-1295 NO DAC 5MG
For research purposes only. Not for human consumption.
CJC-1295 No DAC 5mg — Short-Acting GHRH Research Analogue
CJC-1295 No DAC 5mg is a synthetic GHRH analogue formulated without the Drug Affinity Complex modification. This variant does not bind albumin and therefore produces a shorter, more discrete growth hormone-releasing profile. This characteristic makes it particularly suitable for research protocols requiring acute, time-limited GH stimulation or investigation of pulsatile secretion patterns.
Research Applications
Research utilising CJC-1295 No DAC has focused on GHRH receptor activation dynamics, pulse-dependent GH secretion, and the physiological effects of acute somatotropic stimulation. It has been used extensively in combination with growth hormone secretagogues such as Ipamorelin to study synergistic GH responses and model natural pulsatile GH release. Investigators have also compared this variant to CJC-1295 DAC to understand how half-life extension influences downstream hormonal outcomes.
Formulation & Purity
Supplied as a high-purity white lyophilised powder, this product exceeds >99% purity as verified by HPLC analysis. Its freeze-dried formulation ensures long-term structural stability, maintaining peptide integrity throughout storage and transport. Researchers may reconstitute the compound using bacteriostatic water or a sterile diluent suited to their experimental protocol.
Intended Use
CJC-1295 No DAC 5mg is intended exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic, or medicinal use. All handling and experimentation must be conducted by trained professionals within appropriate controlled laboratory environments.
